Canada markets open in 5 hours 35 minutes

WuXi Biologics (Cayman) Inc. (2269.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
71.400+1.650 (+2.37%)
As of 03:39PM HKT. Market open.
Full screen
Previous Close69.750
Bid71.300 x 0
Ask71.400 x 0
Day's Range69.050 - 72.950
52 Week Range40.300 - 127.300
Avg. Volume22,493,544
Market Cap300.965B
Beta (5Y Monthly)N/A
PE Ratio (TTM)82.07
EPS (TTM)0.870
Earnings DateAug 17, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est117.15
  • CNW Group

    WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore

    WuXi Biologics ("WuXi Bio") (2269.HK), a global leading Contract Research, Development and Manufacturing Organization (CRDMO), today announced a 10-year USD$1.4 billion (S$2 billion) investment plan to expand the company's research, development, and large-scale drug substance and drug product (DS/DP) manufacturing capacity and capabilities in Singapore. This new site will add 120,000L biomanufacturing capacity to WuXi Biologics' global network by 2026 and is anticipated to employ 1,500 research,

  • CNW Group

    WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes

    WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi Biologics.

  • CNW Group

    WuXi Biologics Statement

    We have been made aware of a recent U.S. Commerce Department announcement that two WuXi Biologics (Cayman) subsidiaries in Shanghai and Wuxi will be added to the department's "Unverified List" (UVL) on February 8, 2022. We understand that the reason for this action is because U.S. government agencies have not been able to undertake required end-use verifications in order for certain equipment to be exported from U.S. suppliers. The "Unverified List" is not the U.S. "Entity List" or "Black List"